proposal of Mycobacterium triplex sp. nov.
For several years, the Mycobacteriology Laboratory at the Centers for Disease Control and Prevention (CDC) has routinely reported on an unusual group of organisms described as SAV. This group of slowly growing mycobacteria resembled Mycobacterium avium complex or Mycobacterium simiae by conventional biochemical tests. However, commercial genetic probes designed to detect species of the M. avium complex were negative. Analysis of mycolic acids with high-performance liquid chromatography (HPLC) demonstrated a mycolate pattern that was most consistent with M. simiae (9, 11) . The HPLC analysis revealed several different chromatographic types for this SAV group. Since 1990, the CDC has used the term SAV in reporting this group of organisms. Mycolic-acid profiles, standard biochemical tests, and genetic probe results differentiated these organisms from M. simiae and M. avium. This study reports on the subgroup of SAV which is nonpigmented and nonphotochromogenic. The characteristics of these organisms indicated that they belonged to a new species for which we propose the name Mycobacterium triplex.
MATERIALS AND METHODS
Bacterial strains. Ten strains were studied. Sources of the strains and their designations are shown in Table 1 . Authenticated mycobacterial strains from CDC and the California Department of Health Services, Microbial Diseases Laboratory, Berkeley, used for comparison were M. simiae (TMC 1226), M. avium (ATCC 25291), and M. intracellulare (ATCC 13950).
Growth, biochemical tests, and drug susceptibility. All mycobacterial strains were isolated by standard methods. These strains had been submitted to either CDC or the Microbial Diseases Laboratory for identification as clinical isolates. For testing, subcultures were prepared using Lowenstein-Jensen (LJ) slants and incubated at 35ЊC. Temperature studies were conducted at 42ЊC, 37ЊC, 35ЊC, 33ЊC, 28ЊC, and 25ЊC at 3 weeks of incubation on LJ slants. Colony morphology was determined on LJ slants and 7H10 agar plates at 37ЊC after 3 weeks of growth. Photochromogenicity and pigment production tests were conducted by standard methods at 1 and 3 weeks, respectively (15) . The following tests were performed for differentiation: nitrate reduction, Tween 80 hydrolysis, semiquantitative catalase, 68ЊC heat-stable catalase, urease, arylsulfatase, sodium chloride tolerance, and niacin production. Drug susceptibility tests were performed on Middlebrook 7H10 agar using the proportion method (15) . Drugs used and concentrations are shown in Table 2 .
HPLC. Mycolic-acid pattern analysis was performed according to established procedure (3) . Briefly, whole cells were saponified in methanolic potassium hydroxide solution. After acidification, chloroform extracts containing the mycolic acids were separated from the cellular materials. Mycolic acids were derivatized to bromophenacyl esters. Chromatography was performed using a Waters LCM1 chromatograph (Waters Chromatography, Milford, Mass.) controlled by Millennium software and equipped with a Nova-Pak C 18 column (3.9 by 75 mm), a column heater (31 Ϯ 1ЊC), and a variable wavelength UV detector adjusted to 260 nM. A 10-min methanol and methylene chloride gradient was used as previously described (10) . Patterns generated with this method were visually matched to standard CDC HPLC patterns of authentic species using the relative retention time ratios as calculated by the software. These ratios were derived using a high-molecular-weight external standard (Ribi ImmunoChem Research, Inc., Hamilton, Mont.) as the reference peak (4).
16S rRNA amplification and sequencing. Mycobacterial cells were disrupted by shaking with siliconized glass minibeads in a Mickle apparatus as described previously (20) . Aqueous cellular extracts were reacted with PCR to amplify the 16S gene with oligonucleotides 5Ј GAGAGTTTGATCCTGGCTCAG 3Ј and 5Ј AAGGAGGTGATCCAGCCGCA 3Ј as described previously (7) . Thermocycling conditions included 39 cycles of denaturation at 94ЊC for 1 min, primer annealing at 68ЊC for 3 min, extension at 72ЊC for 2 min, and final extension at 72ЊC for 10 min. QIAquick PCR purification columns (Qiagen Inc., Chatsworth, Calif.) were used to remove unincorporated nucleotides and primers from the amplified DNA. Sequencing reactions were performed using the Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems Division, Perkin-Elmer Corp., Foster City, Calif.) following the manufacturer's specifications. The unincorporated dye terminators and primers were removed from the extension products using Centri-Sep spin columns (Princeton Separations Inc., Adelphia, N.J.). Samples were dried at ambient temperature and resuspended in 6.5 l of loading buffer (5:1; deionized formamide and 30 mg of blue dextran per ml-50 mM EDTA [pH 8.0]). Resuspended products were denatured at 90ЊC for 2 min, and 5 l of each sample was loaded onto a 6% acrylamide gel for analysis.
* Corresponding author. Electrophoretic separation was with an automated ABI Model 373A DNA Sequencer (Applied Biosystems Division) operated at 30 W for 8 h. Sequencing data were generated by examination of almost 1,500 contiguous bases assembled from multiple regions of nucleotide overlap using DNASIS, version 7.0, software (Hitachi Software Engineering America, Ltd., San Bruno, Calif.). Selective 16S rRNA alignment, including the hypervariable region, was analyzed as described below. Sequence analysis. The mycobacterial nucleotide sequences were aligned using the alignment program PILEUP, part of the Genetics Computer Group software package (6) . The M. triplex sequence was aligned with published sequences of 16S rRNA from slowly growing mycobacterial species. Ambiguous positions within the alignment sequence were not analyzed. Regions of alignment uncertainty corresponding to Escherichia coli positions 30 to 47 and 75 to 84 were omitted. Additionally, positions corresponding to E. coli positions 1381 to 1525 were omitted because the contiguous sequence published for M. xenopi (GenBank accession number M61664) was incomplete. For the phylogenetic analysis, this reduced the number of positions used from 1,474 to 1,300. A phylogenetic tree was constructed using the software package PHYLIP (8) . Similarity values were calculated by the Jukes and Cantor method (12) . The neighbor-joining method of Saitou and Nei was used to construct the dendrogram (23) .
Nucleotide sequence accession number. The GenBank nucleotide accession number for M. triplex is U57632.
RESULTS AND DISCUSSION
As shown in Table 1 , the geographic distribution of these strains in the United States was diverse. The isolates were recovered from sputum, lymph nodes, and cerebrospinal fluid.
Cells were acid-alcohol fast by Kinyoun stain. Microscopically, cells were short rods to coccoid. Colonies on LJ and 7H10 media were usually smooth, cream to buff, nonpigmented, and nonphotochromogenic. Visible growth was noted after 14 to 21 days at an optimum temperature of 35ЊC on LJ medium with no growth at 25ЊC, 42ЊC, and 52ЊC.
All of these isolates failed to hybridize with the commercially available genetic probe (Accuprobe, Gen-Probe, Inc., San Diego, Calif.) for M. avium complex. The biochemical reactions of the isolates were compared with the known characteristics of other similar slowly growing strains of mycobacteria (15) . Standard biochemical reactions placed the strains into a group. Strains were negative for niacin production, Tween 80 hydrolysis, and 3-day arylsulfatase and were variable for 14-day arylsulfatase. They did not grow on sodium chloride. Strains were positive for 68ЊC catalase, nitrate reduction, and urease. The semiquantitative catalase pro- duced a Ͼ45-mm column of bubbles. All strains grew on thiophen-2-carboxylic acid hydrazide at 5.0 g/ml. M. triplex strains were similar to M. avium complex in traditional susceptibility testing. All of the isolates were resistant to isoniazid at 1.0 g/ml, streptomycin at 2 g/ml, rifampin at 6.0 g/ml, kanamycin at 5.0 g/ml, and capreomycin at 10.0 g/ml. Eight of the isolates were sensitive to ethambutol at 10.0 g/ ml, and nine were sensitive to ethionamide at 5.0 g/ml. One of the isolates was resistant to both of these drugs. Generally, most strains were resistant to the commonly used antituberculosis drugs (Table 2) .
Strains reported from CDC with the prior designation SAV had been shown to produce HPLC patterns that visually resembled M. simiae (9, 11) . Identification by visual recognition, while somewhat subjective, has the advantage over computer methods because it does not force sample identification (3, 10) . M. avium, M. simiae, and M. triplex produced an HPLC pattern with a triple mycolate cluster. The HPLC patterns for M. triplex and M. simiae were distinctly different from M. avium (Fig. 1) . Major peaks were determined by the HPLC method used and labeled by the software according to relative retention time ratios by comparison with an added internal standard (10) . For clarification, the primary mycolic-acid peaks have been labeled 1 to 5 and a to n (Fig. 1) . Peaks with heights Ͼ2% of the total peak heights eluting between 5.5 min and 10.5 min were used for comparison. Peaks appearing between 4.5 min and 5.5 min for M. triplex (Fig. 1A) did not appear in all isolates and, therefore, were not considered for analysis. Peaks with the same relative retention time (Ϯ0.01 min) were used for alignment of chromatograms. M. triplex and M. simiae both produced a group of mycolates that eluted at 7.0 min. M. avium produced shorter carbon chain-length mycolic acids that emerged before 7.0 min. M. simiae produced a range of mycolates that started emerging with peak b at 7.2 min and terminated at 9.4 min with peak n. Most notable, M. simiae produced peak h and peak n. M. triplex does not have these peaks. Additional distinguishing features of M. triplex versus M. simiae include early eluting mycolates at 7.0 min (peak a), patterns terminating at 9.2 min (peak m), and exhibition of three peaks (a, e, and i) that are not common with M. simiae.
The 16S rRNA gene is highly conserved in certain regions and highly variable in others. Primers designed to the conserved regions have been used to amplify the 16S rRNA sequence for direct sequencing of almost the entire nucleotide sequence (7, 28) . Although homology values demonstrated for the mycobacteria are Ͼ95% (27), a species-specific signature region for mycobacteria has been shown to exist in a hypervariable region corresponding to E. coli 16S rRNA positions 129 to 266 (16) . This variable region has been used for identification and naming of a new species of mycobacteria (1, 2, 5, 13, 14, 17, 18, 24, 25) . Analysis of the 16S rRNA hypervariable region revealed a unique sequence (Fig. 2 and 3 ). All 10 of the strains were identical in this region. Phylogenetic analysis showed a close relationship of M. triplex to M. simiae and the difficult-to-grow M. genavense (Fig. 4) . Homologies of 99.4% were noted to similar organisms ( Table 3 ). The similarity values revealed that M. interjectum is closer to M. simiae and M. genavense than to M. avium (Table 3) . However, the HPLC pattern for M. interjectum is similar to the M. avium pattern and distinctly different from M. simiae and M. genavense. Phylogenetic relatedness schemes based on 16s rRNA also separate slow-growing from fast-growing species (26) (19, 21, 22) . The homogeneous complex formed with M. triplex strains was in this same position, between rapidly and slowly growing mycobacteria. Taxonomic description of M. triplex sp. nov. M. triplex (tripЈleks. L. gen. adj. triplex referring to something consisting of three parts, specifically, the triple-cluster HPLC pattern produced by these isolates). Cells are acid-alcohol fast, short rods to coccoid. Colonies on LJ and 7H10 are cream to buff, nonpigmented, usually smooth, sometimes appearing rough with age, but always nonphotochromogenic. Growth occurs at both 30ЊC and 35ЊC but not at 25ЊC, 42ЊC, or 52ЊC. Strains have a similar drug pattern and are usually resistant to streptomycin, isoniazid, rifampin, ethambutol, ethionamide, kanamycin, thiopene-2-carboxylic acid hydrazide, and capreomycin. They do not react to the commercial genetic probe for M. avium complex. Mycolic acids analyzed by HPLC produce a three-cluster mycolate pattern, most closely resembling that of M. simiae.
Characteristics which differentiate M. triplex from M. avium, M. simiae, and M. genavense. Phenotypic differences were demonstrated among closely related species M. simiae, M. avium, and the new species, M. triplex. M. triplex can be distinguished by its HPLC-mycolic-acid pattern that resembles M. simiae but is clearly distinctive from M. avium. M. triplex is differentiated from M. simiae strains by lack of pigmentation, negative test for niacin, and positive test for nitrate. The abundant growth of M. triplex on LJ differentiates it from M. genavense. M. triplex produced a unique 16S rRNA sequence that is different from all described mycobacteria.
Combined results from HPLC, conventional biochemical testing, and commercial genetic probes were supportive of a new species. Conclusive genetic evidence of a novel species was demonstrated with 16S rRNA analysis.
